PDF herunterladen
Endoscopy 2017; 49(10): 941-948
DOI: 10.1055/s-0043-112492
Original article
© Georg Thieme Verlag KG Stuttgart · New York

Exploring diagnostic and therapeutic implications of endoscopic mucosal resection in EUS-staged T2 esophageal adenocarcinoma

Annieke W. Gotink
1   Department of Gastroenterology and Hepatology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands
,
Manon C. W. Spaander
1   Department of Gastroenterology and Hepatology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands
,
Michael Doukas
2   Department of Pathology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands
,
Thjon J. Tang
3   Department of Gastroenterology and Hepatology, IJsselland Hospital, Capelle aan den IJssel, The Netherlands
,
Paul Didden
1   Department of Gastroenterology and Hepatology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands
,
Bas P. L. Wijnhoven
4   Department of Surgery, Erasmus MC, University Medical Center, Rotterdam, The Netherlands
,
Marco J. Bruno
1   Department of Gastroenterology and Hepatology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands
,
Arjun D. Koch
1   Department of Gastroenterology and Hepatology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands
› Institutsangaben
Weitere Informationen

Publikationsverlauf

submitted 07. November 2016

accepted after revision 08. Mai 2017

Publikationsdatum:
21. Juni 2017 (online)

Auch verfügbar auf
   Lizenzen und Reprints

Siehe auch:

Video Comment on Annieke W. Gotink et al.Endoscopy 2017; 49(10): v33-v33
DOI: 10.1055/s-0043-118134

Siehe auch:

Endoscopic resection in esophageal adenocarcinoma: a basic requirement for future management algorithmsEndoscopy 2017; 49(10): 934-935
DOI: 10.1055/s-0043-118590

Abstract

Background and study aims Treatment strategies for clinical (c)T2N0M0 esophageal adenocarcinoma (EAC) are subject to debate owing to the relative inaccuracy of tumor staging by endoscopic ultrasound (EUS), with profound implications in overstaged patients. We aimed to evaluate the final histological diagnosis of patients initially staged as having a cT2 tumor by EUS, and to assess the value of endoscopic reassessment by an interventional endoscopist, followed by an endoscopic resection when deemed feasible.

Patients and methods Two distinct cohorts of patients with cT2 EAC as determined by EUS were included: a retrospective surgical cohort of patients treated by primary esophagectomy, and a prospective cohort of patients who underwent an endoscopic reassessment by an interventional endoscopist. The main outcome measure was the final pathological (p)T stage.

Results We identified 134 patients with stage T2 EAC from the surgical cohort. In 72 patients treated by primary esophagectomy, 32/72 (44 %) were downstaged to a pT1 tumor. In 12/72 (17 %), the surgical resection specimen showed tumor characteristics that fulfilled the current criteria for a curative endoscopic resection. In 13 prospectively identified patients with cT2N0M0 EAC, an expert endoscopic reassessment was done. In 11/13 (85 %) the lesion appeared endoscopically resectable and a complete endoscopic resection was performed. Histology revealed a pT1 tumor in all 11 patients, with 5/13 (38 %) fulfilling current criteria for a curative endoscopic resection.

Conclusions In this study, 44 % of cT2 EACs were in fact pT1 tumors. Curative treatment by endoscopic resection was achieved in more than a third of these cases. To avoid an unnecessary esophagectomy, an endoscopic reassessment by an interventional endoscopist is recommended for all patients with cT2N0M0 EAC.

 

  • References

  • 1 Pohl H, Welch HG. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst 2005; 97: 142-146
    CrossrefPubMedGoogle Scholar
  • 2 Pennathur A, Gibson MK, Jobe BA. et al. Oesophageal carcinoma. Lancet 2013; 381: 400-412
    CrossrefPubMedGoogle Scholar
  • 3 Hardacker TJ, Ceppa D, Okereke I. et al. Treatment of clinical T2N0M0 esophageal cancer. Ann Surg Oncol 2014; 21: 3739-3743
    CrossrefPubMedGoogle Scholar
  • 4 Speicher PJ, Ganapathi AM, Englum BR. et al. Induction therapy does not improve survival for clinical stage T2N0 esophageal cancer. J Thorac Oncol 2014; 9: 1195-1201
    CrossrefPubMedGoogle Scholar
  • 5 Vallbohmer D, Sisic L, Blank S. et al. Clinically staged cT2 adenocarcinomas of the gastroesophageal junction: accuracy of staging and therapeutic consequences. Oncol Res Treat 2014; 37: 97-104
    CrossrefPubMedGoogle Scholar
  • 6 Crabtree TD, Kosinski AS, Puri V. et al. Evaluation of the reliability of clinical staging of T2 N0 esophageal cancer: a review of the Society of Thoracic Surgeons database. Ann Thorac Surg 2013; 96: 382-390
    CrossrefPubMedGoogle Scholar
  • 7 Fitzgerald RC, di Pietro M, Ragunath K. et al. British Society of Gastroenterology guidelines on the diagnosis and management of Barrettʼs oesophagus. Gut 2014; 63: 7-42
    CrossrefPubMedGoogle Scholar
  • 8 Spechler SJ, Sharma P, Souza RF. et al. American Gastroenterological Association technical review on the management of Barrett's esophagus. Gastroenterology 2011; 140: e18-e52
    CrossrefPubMedGoogle Scholar
  • 9 Evans JA, Early DS, Chandraskhara V. et al. The role of endoscopy in the assessment and treatment of esophageal cancer. Gastrointestinal Endoscopy 2013; 77: 328-334
    CrossrefPubMedGoogle Scholar
  • 10 van Hagen P, Hulshof MCCM, van Lanschot JJB. et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. NEJM 2012; 366: 2074-2084
    CrossrefPubMedGoogle Scholar
  • 11 Khanna LG, Gress FG. Preoperative evaluation of oesophageal adenocarcinoma. Best Pract Res Clin Gastroenterol 2015; 29: 179-191
    CrossrefPubMedGoogle Scholar
  • 12 Didden P, Spaander MCW, Wijnhoven BPL. et al. Improving the quality of pretreatment staging in patients with esophageal carcinoma – a fast track study. Acta Oncologica 2012; 51: 362-367
    CrossrefPubMedGoogle Scholar
  • 13 O’Farrell N, Malik V, Donohoe C. et al. Appraisal of Staging Endoscopic Ultrasonography in a Modern High-Volume Esophageal Program. World J Surg 2013; 37: 1666-1672
    CrossrefPubMedGoogle Scholar
  • 14 Pech O, Günter E, Dusemund F. et al. Accuracy of endoscopic ultrasound in preoperative staging of esophageal cancer: results from a referral center for early esophageal cancer. Endoscopy 2010; 42: 456-461
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 15 Zhang JQ, Hooker CM, Brock MV. et al. Neoadjuvant chemoradiation therapy is beneficial for clinical stage T2 N0 esophageal cancer patients due to inaccurate preoperative staging. Ann Thorac Surg 2012; 93: 429-435 ; discussion 436–427
    CrossrefPubMedGoogle Scholar
  • 16 The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon: November 30 to December 1, 2002. Gastrointest Endosc; 2003 58. S3-S43
    PubMedGoogle Scholar
  • 17 Shaheen NJ, Falk GW, Iyer PG. et al. ACG Clinical Guideline: Diagnosis and management of Barrett's esophagus. Am J Gastroenterol 2016; 111: 30-50 , quiz 51
    CrossrefPubMedGoogle Scholar
  • 18 Fotis D, Doukas M, Wijnhoven BPL. et al. Submucosal invasion and risk of lymph node invasion in early Barrett’s cancer; potential impact of different classification systems on patient management. United European Gastroenterol J 2015; 3: 505-513
    PubMedGoogle Scholar
  • 19 Boys JA, Worrell SG, Chandrasoma P. et al. Can the risk of lymph node metastases be gauged in endoscopically resected submucosal esophageal adenocarcinomas? A multi-center study. J Gastrointest Surg 2016; 20: 6-12 ; discussion 12
    CrossrefPubMedGoogle Scholar
  • 20 Manner H, Pech O, Heldmann Y. et al. The frequency of lymph node metastasis in early-stage adenocarcinoma of the esophagus with incipient submucosal invasion (pT1b sm1) depending on histological risk patterns. Surg Endosc 2015; 29: 1888-1896
    CrossrefPubMedGoogle Scholar
  • 21 Sepesi B, Watson TJ, Zhou D. et al. Are endoscopic therapies appropriate for superficial submucosal esophageal adenocarcinoma? An analysis of esophagectomy specimens. J Am Coll Surg 2010; 210: 418-427
    CrossrefPubMedGoogle Scholar
  • 22 Alvarez Herrero L, Pouw RE, van Vilsteren FG. et al. Risk of lymph node metastasis associated with deeper invasion by early adenocarcinoma of the esophagus and cardia: study based on endoscopic resection specimens. Endoscopy 2010; 42: 1030-1036
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 23 Choi J, Kim SG, Kim JS. et al. Comparison of endoscopic ultrasonography (EUS), positron emission tomography (PET), and computed tomography (CT) in the preoperative locoregional staging of resectable esophageal cancer. Surg Endosc 2010; 24: 1380-1386
    CrossrefPubMedGoogle Scholar
  • 24 Puli SR, Reddy JB, Bechtold ML. et al. Staging accuracy of esophageal cancer by endoscopic ultrasound: a meta-analysis and systematic review. World J Gastroenterol 2008; 14: 1479-1490
    CrossrefPubMedGoogle Scholar
  • 25 Rice TW, Mason DP, Murthy SC. et al. T2N0M0 esophageal cancer. J Thorac Cardiovasc Surg 2007; 133: 317-324
    CrossrefPubMedGoogle Scholar
  • 26 Lee L, Ronellenfitsch U, Hofstetter WL. et al. Predicting lymph node metastases in early esophageal adenocarcinoma using a simple scoring system. J Am Coll Surg 2013; 217: 191-199
    CrossrefPubMedGoogle Scholar
  • 27 Leers JM, DeMeester SR, Oezcelik A. et al. The prevalence of lymph node metastases in patients with T1 esophageal adenocarcinoma a retrospective review of esophagectomy specimens. Ann Surg 2011; 253: 271-278
    CrossrefPubMedGoogle Scholar
  • 28 Alvarez Herrero L, Pouw RE, van Vilsteren FG. et al. Safety and efficacy of multiband mucosectomy in 1060 resections in Barrett's esophagus. Endoscopy 2011; 43: 177-183
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 29 Pech O, May A, Manner H. et al. Long-term efficacy and safety of endoscopic resection for patients with mucosal adenocarcinoma of the esophagus. Gastroenterology 2014; 146: 652-660 .e651
    CrossrefPubMedGoogle Scholar
  • 30 Pouw RE, Peters FP, Sempoux C. et al. Stepwise radical endoscopic resection for Barrett's esophagus with early neoplasia: report on a Brussels' cohort. Endoscopy 2008; 40: 892-898
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 31 Terheggen G, Horn EM, Vieth M. et al. A randomised trial of endoscopic submucosal dissection versus endoscopic mucosal resection for early Barrett's neoplasia. Gut 2017; 66: 783-793
    CrossrefPubMedGoogle Scholar
  • 32 Komeda Y, Bruno M, Koch A. EMR is not inferior to ESD for early Barrett’s and EGJ neoplasia: An extensive review on outcome, recurrence and complication rates. Endosc Int Open 2014; 2: E58-E64
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 33 Metzger R, Bollschweiler E, Vallbohmer D. et al. High volume centers for esophagectomy: what is the number needed to achieve low postoperative mortality?. Dis Esophagus 2004; 17: 310-314
    CrossrefPubMedGoogle Scholar
  • 34 May A, Gunter E, Roth F. et al. Accuracy of staging in early oesophageal cancer using high resolution endoscopy and high resolution endosonography: a comparative, prospective, and blinded trial. Gut 2004; 53: 634-640
    CrossrefPubMedGoogle Scholar
  • 35 Pouw RE, Heldoorn N, Alvarez Herrero L. et al. Do we still need EUS in the workup of patients with early esophageal neoplasia? A retrospective analysis of 131 cases. Gastrointest Endosc 2011; 73: 662-668
    CrossrefPubMedGoogle Scholar